RR

Raja Ram Singh

Active Director Director DIN 08633515
DIN 08633515 First appointment Dec 2019 Primary industry Pharmaceuticals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Raja Ram Singh

Data last updated:

Raja Ram Singh is a Director at Deear Medical Private Limited (since 2019). The company operates in Pharmaceuticals. Deear Medical Private Limited reported revenue of ₹1.01 Cr (FY 2024).

DIN 08633515
Primary Designation Director
Industry Pharmaceuticals
First Appointment 09 Dec 2019
Oldest Company Age 28 yrs
Largest company Deear Medical Private Limited · ₹1.01 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deear Medical Private Limited U51109UP1998PTC206410
Director09 Dec 20191998₹1.01 Cr (FY 2024)Active

Board colleagues of Raja Ram Singh

Directorship timeline

Open interactive timeline →
Deear Medical Private Limited
Premium access

Shareholding and investment profile for Raja Ram Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raja Ram Singh

Raja Ram Singh currently holds 1 directorship: Deear Medical Private Limited (Director, since 09 Dec 2019, revenue ₹1.01 Cr (FY 2024)).

Raja Ram Singh was first appointed on 09 Dec 2019 as Director at Deear Medical Private Limited.

The current boards of Raja Ram Singh's companies include Naveen Srivastava (Deear Medical Private Limited), Ram Naresh Singh (Deear Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available